Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”
Funding
Conflicts of Interest
References
- van der Pluijm, R.W.; Visser, B.J.; Dondorp, A.M. Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781. J. Clin. Med. 2022, 11, 2934. [Google Scholar] [CrossRef]
- Weitzman, R.; Calfon-Peretz, O.; Saha, T.; Bloch, N.; Ben Zaken, K.; Rosenfeld, A.; Amitay, M.; Samson, A.O. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781. [Google Scholar] [CrossRef] [PubMed]
- Dabour, R.; Meirson, T.; Samson, A.O. Global antibiotic resistance is mostly periodic. J. Glob. Antimicrob. Resist. 2016, 7, 132–134. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Calfon-Peretz, O.; Weitzman, R.; Amitay, M.; Samson, A.O. Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”. J. Clin. Med. 2022, 11, 2972. https://doi.org/10.3390/jcm11112972
Calfon-Peretz O, Weitzman R, Amitay M, Samson AO. Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”. Journal of Clinical Medicine. 2022; 11(11):2972. https://doi.org/10.3390/jcm11112972
Chicago/Turabian StyleCalfon-Peretz, Ortal, Rachel Weitzman, Moshe Amitay, and Abraham O. Samson. 2022. "Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”" Journal of Clinical Medicine 11, no. 11: 2972. https://doi.org/10.3390/jcm11112972